Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/32077
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMatthiesson K.L.en
dc.contributor.authorMcLachlan R.I.en
dc.contributor.authorO'Donnell L.en
dc.contributor.authorFrydenberg M.en
dc.contributor.authorRobertson D.M.en
dc.contributor.authorStanton P.G.en
dc.contributor.authorMeachem S.J.en
dc.date.accessioned2021-05-14T10:51:33Zen
dc.date.available2021-05-14T10:51:33Zen
dc.date.copyright2006en
dc.date.created20061019en
dc.date.issued2012-10-17en
dc.identifier.citationJournal of Clinical Endocrinology and Metabolism. 91 (10) (pp 3962-3969), 2006. Date of Publication: October 2006.en
dc.identifier.issn0021-972Xen
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/32077en
dc.description.abstractContext:. Male hormonal contraception via gonadotropin and intratesticular androgen withdrawal disrupts spermatogenesis at two principal sites: 1) spermatogonial maturation, and 2) spermiation. Objective(s): The objective of this study was to explore the relative dependence of each stage of germ cell development on FSH and LH/intratesticular androgen action. Design, Setting, and Participant(s): Eighteen men enrolled in this prospective, randomized 14-wk study at Prince Henrys Institute. Intervention(s): Subjects (n = 6/group) were assigned to 6 wk of 1) testosterone (T) implant (4 x 200 mg sc once)+depot medroxy progesterone acetate (DMPA; 150 mg im once); 2) T implant+DMPA+FSH (300 IU sc twice weekly); and 3) T implant+DMPA+human chorionic gonadotropin (hCG; 1000 IU sc twice weekly as an LH substitute). Men then underwent a vasectomy and testicular biopsy with previously reported control data used for comparison. Main Outcome Measure(s): Germ cell number (assessed by the optical disector stereological approach) and intratesticular androgen levels were determined. Result(s): T+DMPA alone significantly suppressed type B spermatogonia, preleptotene through to pachytene spermatocytes, and round spermatids from control (P < 0.05). All germ cell subtypes were maintained at control levels by either FSH or LH activity, except pachytene spermatocytes, which were found to be lower in the hCG vs. FSH (P < 0.01) and control groups (P < 0.05). Conclusion(s): FSH and LH maintained spermatogenesis independently in this gonadotropin-suppressed model. Compared with LH, FSH showed better maintenance of pachytene spermatocyte number, whereas improved conversion to round spermatids was suggested with hCG treatment. Future contraceptive treatment strategies must consider independent regulation of spermatogenesis by both FSH and LH/intratesticular androgens for maximum efficacy. Copyright © 2006 by The Endocrine Society.en
dc.languageenen
dc.languageEnglishen
dc.publisherEndocrine Society (8401 Connecticut Ave. Suite 900, Chevy Chase MD 20815, United States)en
dc.titleThe relative roles of follicle-stimulating hormone and luteinizing hormone in maintaining spermatogonial maturation and spermiation in normal men.en
dc.typeArticleen
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1210/jc.2006-1145en
dc.publisher.placeUnited Statesen
dc.identifier.pubmedid16895950 [http://www.ncbi.nlm.nih.gov/pubmed/?term=16895950]en
dc.identifier.source44536871en
dc.identifier.institution(Matthiesson, McLachlan, O'Donnell, Robertson, Stanton, Meachem) Prince Henrys Institute, Monash University, Monash Medical Centre, Clayton, Vic. 3168, Australia (Matthiesson, McLachlan, Robertson) Departments of Obstetrics and Gynaecology, Monash University, Monash Medical Centre, Clayton, Vic. 3168, Australia (Frydenberg) Department of Urology, Monash University, Monash Medical Centre, Clayton, Vic. 3168, Australia (Matthiesson) Prince Henrys Institute, P.O. Box 5152, Clayton, Vic. 3168, Australiaen
dc.description.addressK.L. Matthiesson, Prince Henrys Institute, P.O. Box 5152, Clayton, Vic. 3168, Australia. E-mail: kati.matthiesson@princehenrys.orgen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2012 Elsevier B.V., All rights reserved.en
dc.identifier.authoremailMatthiesson K.L.; kati.matthiesson@princehenrys.orgen
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.openairetypeArticle-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptUrology-
Appears in Collections:Articles
Show simple item record

Page view(s)

26
checked on Feb 11, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.